Omada Health Debuts at $19.00/share
Omada Health (NASDAQ:OMDA) priced its IPO at $19 per share on Thursday, in the middle of the expected range.The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million.The company filed its initial prospectus in May and updated the document with an expected pricing range of $18 to $20 per share. At the IPO price, Omada is worth about $1.1 billion, though that number could be higher on a fully diluted basis. That’s right around its private market valuation from 2022, when Omada announced a $192-million funding round that pushed its valuation above $1 billion.U.S. Venture Partners, Andreessen Horowitz and Fidelity’s FMR LLC are the largest outside shareholders in the company, each owning between 9% and 10% of the stock.Omada offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension. Sean Duffy, Omada’s CEO, co-founded the company with Andrew DiMichele and Adrian James, who have both moved on to other ventures.It’s the second digital health IPO in a matter of weeks following an extended drought for the industry. Digital physical therapy startup Hinge Health (NYSE:HNGE) debuted on the New York Stock Exchange in May.
Recent Posts

Europe Faces Most Difficult Moment in Bid to Avoid Split With US

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Hastings Racecourse in Vancouver to shut down permanently, operator says

Russia’s Vital Oil Trade With India Is Down, But Not Out

Copper Quest Closes $1,927,000 Private Placement

This TSX stock was up 17% this week and it could gain another 36%, analysts say

AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million

Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs

Emera Renews At-The-Market Equity Program

CRA warns of ‘aggressive tax schemes’ involving critical illness insurance


